China Testing & Certification International GroupLtd Bilan de santé

Santé financière contrôle des critères 3/6

China Testing & Certification International GroupLtd has a total shareholder equity of CN¥2.5B and total debt of CN¥1.5B, which brings its debt-to-equity ratio to 60.1%. Its total assets and total liabilities are CN¥5.2B and CN¥2.6B respectively. China Testing & Certification International GroupLtd's EBIT is CN¥399.8M making its interest coverage ratio 9.6. It has cash and short-term investments of CN¥234.4M.

Informations clés

60.1%

Ratio d'endettement

CN¥1.51b

Dette

Ratio de couverture des intérêts	9.6x
Argent liquide	CN¥234.38m
Fonds propres	CN¥2.51b
Total du passif	CN¥2.65b
Total des actifs	CN¥5.16b

Mises à jour récentes de la santé financière

Is China Testing & Certification International GroupLtd (SHSE:603060) A Risky Investment?

Sep 27

Does China Testing & Certification International GroupLtd (SHSE:603060) Have A Healthy Balance Sheet?

Jun 07

Recent updates

Is China Testing & Certification International GroupLtd (SHSE:603060) A Risky Investment?

Sep 27

Does China Testing & Certification International GroupLtd (SHSE:603060) Have A Healthy Balance Sheet?

Jun 07

Concerns Surrounding China Testing & Certification International GroupLtd's (SHSE:603060) Performance

May 07

Earnings Miss: China Testing & Certification International Group Co.,Ltd. Missed EPS And Analysts Are Revising Their Forecasts

May 02

Analyse de la situation financière

Passif à court terme: 603060's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥1.9B).

Passif à long terme: 603060's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥712.6M).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 603060's net debt to equity ratio (50.8%) is considered high.

Réduire la dette: 603060's debt to equity ratio has increased from 0% to 60.1% over the past 5 years.

Couverture de la dette: 603060's debt is not well covered by operating cash flow (16.6%).

Couverture des intérêts: 603060's interest payments on its debt are well covered by EBIT (9.6x coverage).

China Testing & Certification International GroupLtd Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Is China Testing & Certification International GroupLtd (SHSE:603060) A Risky Investment?

Does China Testing & Certification International GroupLtd (SHSE:603060) Have A Healthy Balance Sheet?

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

China Testing & Certification International Group Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 22%

Is China Testing & Certification International GroupLtd (SHSE:603060) A Risky Investment?

New minor risk - Share price stability

Price target decreased by 7.5% to CN¥10.28

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Investor sentiment improves as stock rises 17%

China Testing & Certification International Group Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Dividend of CN¥0.11 announced

Does China Testing & Certification International GroupLtd (SHSE:603060) Have A Healthy Balance Sheet?

Concerns Surrounding China Testing & Certification International GroupLtd's (SHSE:603060) Performance

Price target decreased by 7.2% to CN¥11.61

Consensus EPS estimates fall by 13%

New major risk - Financial position

Earnings Miss: China Testing & Certification International Group Co.,Ltd. Missed EPS And Analysts Are Revising Their Forecasts

China Testing & Certification International Group Co.,Ltd., Annual General Meeting, May 20, 2024

Full year 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.32 in FY 2022)

China Testing & Certification International Group Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Investor sentiment deteriorates as stock falls 16%

Full year 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.32 in FY 2022)

China Testing & Certification International Group Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024

Price target decreased by 7.4% to CN¥12.83

Consensus EPS estimates fall by 13%

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 13%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Full year 2022 earnings released: EPS: CN¥0.35 (vs CN¥0.35 in FY 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Consensus EPS estimates fall by 10%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

China Building Material Test & Certification Group Co., Ltd. (SHSE:603060) agreed to acquire a 49% stake in Hunan Huake Testing Technology Co., Ltd for CNY 46.3 million.

Investor sentiment improved over the past week

Price target decreased to CN¥19.07

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Consensus forecasts updated

Third quarter 2021 earnings released: EPS CN¥0.083 (vs CN¥0.13 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.091 (vs CN¥0.12 in 2Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.12 in 2Q 2020)

China Building Material Test & Certification Group Co., Ltd. (SHSE:603060) intends to purchase 65% stake in Liaoning Fengtian Testing Technology Co., Ltd. from Yitian Enterprise Management Consulting Partnership (Limited Partnership) and Liaoning Fuhua Glass Co., Ltd. for CNY 58.8 million.

First quarter 2021 earnings released: CN¥0.033 loss per share (vs CN¥0.086 loss in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.54 (vs CN¥0.48 in FY 2019)

Investor sentiment improved over the past week

China Building Material Test & Certification Group Co., Ltd. to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day high: CN¥23.71

Revenue beats expectations, earnings disappoint

Full year 2020 earnings released: EPS CN¥0.53

Revenue beats expectations, earnings disappoint

New 90-day high: CN¥22.06

Third quarter earnings released

New 90-day low: CN¥18.71

New 90-day low: CN¥18.94

First half earnings released

Price target raised to CN¥21.04

China Building Material Test & Certification Group Co., Ltd. to Report First Half, 2020 Results on Aug 21, 2020

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines